XML 54 R22.htm IDEA: XBRL DOCUMENT v3.25.3
Share-Based Payments
 12 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Share-Based Payments
As of September 30, 2025, the Company had three share-based compensation plans: the Second Amended and Restated 2018 Stock Incentive Plan (the “Second A&R 2018 Plan”), the Second Amended and Restated 2009 Incentive Stock Plan (the “2009 Plan”) and the 2000 Incentive Stock Plan (the “2000 Plan”). New awards granted after January 2024 are issued under the Second A&R 2018 Plan. The Second A&R 2018 Plan provides for the award of restricted share equivalents (“RSEs”), including performance restricted share equivalents (“PRSEs”), share options, share appreciation rights, restricted shares and other share-based awards covering the Company’s common stock to the Company’s directors, officers and employees, and other individuals performing services for the Company and its affiliates. The maximum number of shares authorized for issuance under the 2018 Plan is 17.9, of which 2.4 were available for future awards as of September 30, 2025.
Share options are granted at the market price on the grant date and generally vest ratably over three years. These awards typically have a maximum term of ten years. PRSEs and RSEs may also be granted. Option shares and prices, and PRSEs and RSEs, are adjusted in conjunction with stock splits and other recapitalizations, so that the holder is in the same economic position before and after these equity transactions.
The Company uses the straight-line method of recognizing compensation cost. Total compensation costs charged against earnings before income taxes for the Company’s share-based compensation arrangements were $24.5, $26.5 and $27.5 for fiscal 2025, 2024 and 2023, respectively, and were recorded in SG&A. The total income tax benefit recognized for share-based compensation arrangements was $5.8, $6.3 and $6.6, for fiscal 2025, 2024 and 2023, respectively. RSEs, PRSEs and shares issued for share option exercises under the Company’s share-based compensation programs are generally issued from treasury shares.
 
Share Options
The following table summarizes Share Option activity during fiscal 2025:
SharesWeighted-Average Exercise PriceWeighted-Average Remaining Contractual Term
(in years)		Aggregate Intrinsic Value
Outstanding as of October 1, 2024
1.1 $42.93 
Granted— — 
Canceled and Expired
(0.1)74.10 
Exercised— — 
Outstanding as of September 30, 2025
1.0 $39.78 4.75$— 
Vested and unvested expected to vest as of September 30, 2025
1.0 $39.78 4.75$— 
Exercisable as of September 30, 2025
0.9 $40.36 
An immaterial number of share options were exercised in fiscal 2025, 2024 and 2023.
The Company estimates the grant-date fair value of share option awards using the Black-Scholes option pricing model. The expected volatility is determined based on historical volatility. The Company utilizes the simplified method in estimating the share option life as the Company does not have sufficient historical share option experience to estimate the share option life. During fiscal 2025 and 2024, the Company granted non-qualified share option awards to certain executives and non-executive employees of nil and 0.1, respectively, with a grant-date fair value of nil and $2.1, respectively. The following table presents the Company’s weighted average fair value per option and the assumptions utilized in the Black-Scholes option pricing model:
Fiscal Year
2024
Weighted-average fair value per share option$13.48 
Expected volatility41.0 %
Risk-free interest rate4.67 %
Expected share option life (in years)6.0
Dividend yield1.75 %
As of September 30, 2025, there was an estimated $0.8 of total unrecognized compensation costs related to share option awards, which will be recognized over a weighted-average period of 1.7 years.

Restricted Share Equivalents
The following table summarizes RSE award activity during fiscal 2025:
SharesWeighted-Average
Grant Date Estimated Fair
Value
Non-vested at October 1, 2024
1.0 $37.62 
Granted0.5 35.56 
Vested(0.4)38.58 
Canceled(0.1)36.82 
Non-vested at September 30, 2025
1.0 38.18 
The estimated fair value of the award is determined using the closing share price of the Company’s common stock on the date of grant.
As of September 30, 2025, there was an estimated $21.5 of total unrecognized compensation costs related to RSEs, which will be recognized over a weighted-average period of 1.2 years. The weighted-average estimated fair value per RSE granted in fiscal 2025, 2024 and 2023 was $35.56, $34.54, and $40.17, respectively. The estimated fair value of RSEs vested in fiscal 2025, 2024 and 2023 was $16.8, $15.6, and $20.2, respectively.
Performance Restricted Share Equivalents
The following table summarizes PRSE award activity during fiscal 2025:
SharesWeighted-Average
Grant Date Estimated Fair
Value
Non-vested at October 1, 2024
0.5 $55.06 
Granted0.2 46.84 
Vested(0.1)65.78 
Non-vested at September 30, 2025
0.6 49.43 
As of September 30, 2025, there was an estimated $11.4 of total unrecognized compensation costs related to PRSEs, which will be recognized over a weighted-average period of 1.3 years. The weighted-average estimated fair value per PRSE granted in fiscal 2025, 2024 and 2023 was $46.84, $45.96, and $58.55, respectively. The estimated fair value of PRSEs vested in fiscal 2025 was $7.7.
For PRSE awards granted subsequent to fiscal 2021, awards will vest by comparing the Company’s TSR during a certain three year period to the respective TSRs of companies in a selected performance peer group. Based upon the Company’s ranking in its performance peer group, a recipient of the PRSE award may earn a total award ranging from 0% to 200% of the target award. The fair value of each PRSE was estimated on the grant date using a Monte Carlo simulation. The assumptions for conducting the Monte Carlo simulation for PRSE awards are summarized in the following table.
Fiscal
202520242023
Expected term (in years)3.03.03.0
Expected stock price volatility29.5 %31.8 %48.2 %
Risk-free interest rate4.19 %4.83 %4.14 %
Fair value (per award granted)$47.12 $45.96 $58.55